Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria.
Cosson V, Fu R, Kulasekararaj A, Nishimura JI, Panse J, Röth A, Scheinberg P, Tong H, Yoon SS, Beveridge L, Gotanda K, Jaminion F, Henrich A, Lundberg P, Shi D, Sreckovic S, Zhang Y, Zhang Z, Benkali K, Buatois S.
Cosson V, et al. Among authors: yoon ss.
Br J Clin Pharmacol. 2025 Jan 21. doi: 10.1111/bcp.16394. Online ahead of print.
Br J Clin Pharmacol. 2025.
PMID: 39835421